AMN Stock Forecast & Price Target

AMN Healthcare Services Inc demonstrated solid operational resilience with its second-quarter results, reporting revenue of $658.2 million, surpassing estimates and consensus, despite a year-over-year decline of 11%. The company's gross margin has shown consistent improvement, increasing by 120 basis points sequentially to 29.8%, exceeding internal guidance, which reflects effective cost management and operational efficiencies. Furthermore, AMN's historical performance indicates an average revenue surprise of 3% and an EBITDA surprise of 12% over the past four quarters, underscoring its financial stability and adaptive strategies in a competitive market.

AMN Healthcare Services Inc reported a decrease in segment revenues across its major segments, with nurse and allied solutions revenue falling by 9% year-over-year to $101.8 million, and the physician and leadership solutions segment declining by 14% year-over-year to $381.9 million, indicating significant challenges within its core business areas. Furthermore, the company experienced a contraction in average travelers on assignment, which decreased by 3% quarter-over-quarter, leading to a decline in operating margin by 30 basis points to 7.5%. Additionally, the substantial 31% year-over-year decline in Vendor Management System (VMS) revenue underscores the competitive pressures and operational difficulties AMN Healthcare faces in the current market environment.